Ethosuximide is a succinimide anticonvulsant, used mainly in absence seizures. It is sold by Pfizer under the name Zarontin and was once also sold under the name Emeside, both of which were discontinued from the United Kingdom market in capsule form in November of 2005. It is approved for absence seizures. Ethosuximide is considered the first choice drug for treating absence seizures in part because it lacks the idiosyncratic hepatotoxicity...
Keep reading...